Comparative effects of fosinopril and irbesartan on hematopoiesis in essential hypertensives

Renal Failure

Volumn 26, Issue 4, 2004, Pages 399-404

  Robles, Nicolás Roberto ^a   Angulo, E ^a   Grois, J ^a   Barquero, A ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Angiotensin; Angiotensin conversing enzyme inhibitors; Angiotensin receptor antagonist; Hematopoiesis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOSINOPRIL; HEMOGLOBIN; HYDROCHLOROTHIAZIDE; IRBESARTAN;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ENZYME IMMUNOASSAY; ERYTHROPOIESIS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART RATE; HEMATOCRIT; HEMATOPOIESIS; HUMAN; MALE; MEAN CORPUSCULAR HEMOGLOBIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIPHENYL COMPOUNDS; ERYTHROCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; FOSINOPRIL; HEMATOPOIESIS; HEMOGLOBINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; TIME FACTORS;

EID: 4444257585     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120039824     Document Type: Article

References (25)

1. Sauron, C.; Berthoux, P.; Berthoux, F.; Alamartine, E.; Diab, N.; Broyet, C.; Hacini, J. New insights and treatment in post-transplant polycythemia (erythrocytosis) of renal recipients. Transplant. Proc. 1993, 25, 1032-1033.
2. Julian, B.A.; Gaston, R.S.; Barker, C.V.; Krystal, G.; Diethelm, A.G.; Curtis, I.J.I. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int. 1994, 1397-1403.
3. Charytan, C.; Goldfarb-Rumyantzev, A.; Wang, Y.F.; Schwenk, M.H.; Spinowitz, B.S. Effect of angiotensin-converting enzyme inhibitor of response to erythropoietin therapy in chronic dialysis patients. Am. J. Nephrol. 1998, 18, 498-503.
4. Labeew, M.; Prost, N.F.; Daoud, S.; Lapra, C.; Zech, P.; Pozet, N. Renal venous erythropoietin concentration in hypertensive patients with unilateral renal disease. Nephrol. Dial. Transplant. 1992, 7, 1190-1193.
5. Vlahakos, D.V.; Kosmas, E.N.; Dimopoulou, I.; Ikonomou, E.; Jullien, G.; Vassilakos, P.; Marathias, K.P. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am. J. Med. 1999, 106, 158-164.
6. Jensen, J.D.; Eiskjaer, H.; Bagger, J.P.; Pedersen, E.B. Elevated serum level of erythropoietin in congestive heart failure related to renal function. J. Intern. Med. 1993, 233, 125-130.
7. Gould, A.B.; Goodman, S.; DeWolf, R.; Onesti, G.; Swartz, C. Interrelation of the renin-angiotensin system and erythropoietin in rats. J. Lab. Clin. Med. 1980, 96, 523-534.
8. Nakao, K.; Shirakura, T.; Azuma, M.; Maekawa, T. Studies on erythropoietic action of angiotensin. II. Blood 1967, 29, 754-760.
9. Hirakata, H.; Onoyama, K.; Hori, K.; Fujishima, M. Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients. Clin. Nephrol. 1986, 26, 27-32.
10. Walter, J. Does captopril decreases the effect of human recombinant erythropoietin in hemodialysis patients? Nephrol. Dial. Transplant. 1993, 8, 1428.
11. Danovitch, G.M.; Jamgotchian, N.J.; Eggena, P.H.; Paul, W.; Barrett, J.D.; Wilkinson, A.; Lee, D.B. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism. Transplantation 1995, 60, 132-137.
12. Torregrosa, J.V.; Campistol, J.M.; Montesinos, M.; Rogado, A.G.; Oppenheimer, F.; Andreu, J. Efficacy of captopril on posttransplant erythrocytosis. Transplantation 1994, 58, 311-314.
13. Volpe, M.; Tritto, C.; Testa, U.; Rao, M.A.; Martucci, R.; Mirante, A.; Enea, I.; Russo, R.; Rubattu, S.; Condorelli G.L. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am. J. Cardiol. 1994, 74, 468-473.
14. Sica, D.A. Pharmacology and clinical efficacy of angiotensin receptor blockers. Am. J. Hypertens. 2001, 14, 242S-247S.
15. Rell, K.; Koziak, K.; Jarzyo, I.; Lao, M.; Gaciong, Z. Correction of posttransplant erythrocytosis with enalapril. Transplantation 1994, 57, 1059-1063.
16. Julian, B.A.; Brantley, R.R., Jr.; Barker, C.V.; Stopka, T.; Gaston, R.S.; Curtis, J.J.; Lee, J.Y.; Prchal, J.T. Losartan, an angiotensin II type 1 receptor antagonist lower hematocrit in post transplant erythrocytosis. J. Am. Soc. Nephrol. 1998, 9, 1104-1108.
17. Hortal, L.; Fernandez, A.; Vega, N.; Rodriguez, J.C.; Losada, A.; Lorenzo, M.; Plaza, C.; Palop, L. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis. Transplant. Proc. 1998, 30, 2128.
18. Vlahakos, D.V.; Marathias, K.P.; Kosmas, E.N. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. Ann. Intern. Med. 2001, 134, 426-427.
19. Glicklich, D.; Kapoian, T.; Mian, H.; Gilman, J.; Tellis, V.; Crozat, H. Effects of erythropoietin, I.I. angiotensin, and angiotensin converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis. Transplantation 1999, 66, 62-66.
20. Gould, A.B.; Goodman, S.A.; Green, D. An in vivo effect of renin on erythropoietin formation. Lab. Invest. 1973, 28, 719-722.
21. Anagnosotou, A.; Baranowski, R.; Pillay, V.K.G.; Kurtzman, N.; Vercilloti, G.; Fried, W. Effect of renin on extrarenal erythropoietin production. J. Lab. Clin. Med. 1976, 88, 707-715.
22. Nakao, K.; Shirakura, T.; Azuma, M.; Maekawa, T. Studies on erythropoietic action of angiotensin II. Blood 1967, 29, 754-760.
23. Donnelly, S.; Shah, B.R. Erythropoietin deficiency in hyporeninemia. Am. J. Kidney Dis. 1999, 33, 947-953.
24. Mrug, M.; Stopka, K.; Julian, B.A.; Prchal, J.T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J. Clin. Invest. 1997, 100, 2310-2314.
25. Wolf, G.; Neilson, E. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 1993, 3, 1531-1540.